Kidney & Urinary

Researchers are conducting research to examine the behavioral effects of medications and alcohol.

Researchers invite you to participate in a research study about bone loss (osteoporosis) in patients on dialysis. Risk of fracture is not the only concern with bone loss, which is also associated with the increase in heart calcifications responsible for the high death rate of dialysis patients.

If you are newly diagnosed or experience a relapse, you may be eligible to participate in a clinical trial to determine whether an investigational treatment, when added to either rituximab or cyclophosphamide can improve your vasculitis disease activity, kidney function, and/or quality of life.